1887

Abstract

infection (CDI) is a toxin-mediated intestinal disease. Toxin A, toxin B and binary toxin are believed to be responsible for the pathogenesis of CDI, which is characterized by massive infiltration of neutrophils at the infected intestinal mucosa. IL-17 is one of the cytokines that play critical roles in several inflammatory and immunological diseases through various actions, including promoting neutrophil recruitment. The aim of this study was to examine the role of this cytokine in CDI by employing IL-17 A and F double knockout (IL-17 KO) mice for the CDI model. We demonstrated that IL-17 KO mice were more resistant to CDI than WT mice using several factors, such as diarrhoea score, weight change and survival rate. Although the bacterial numbers of in faeces were not different, the inflammatory mediator levels at the large intestine on day 3 post-infection were attenuated in IL-17 KO mice. Finally, we showed that infiltration of neutrophils, but not macrophages, in the large intestine was significantly decreased in IL-17 KO mice compared to WT mice. In conclusion, the data demonstrate that endogenous IL-17 may be a factor determining the severity of CDI in mice. Although the mechanism is totally unknown, IL-17-mediated inflammatory responses, such as cytokine/chemokine production and neutrophil accumulation, may be plausible targets for future investigations.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000273
2016-08-01
2020-04-01
Loading full text...

Full text loading...

/deliver/fulltext/jmm/65/8/821.html?itemId=/content/journal/jmm/10.1099/jmm.0.000273&mimeType=html&fmt=ahah

References

  1. Aspinall S. T., Hutchinson D. N.. 1992; New selective medium for isolating Clostridium difficile from faeces. J Clin Pathol45:812–814 [CrossRef][PubMed]
    [Google Scholar]
  2. Buonomo E. L., Madan R., Pramoonjago P., Li L., Okusa M. D., Petri W. A., Jr.. 2013; Role of interleukin 23 signaling in Clostridium difficile colitis. J Infect Dis208:917–920 [CrossRef][PubMed]
    [Google Scholar]
  3. Chen X., Katchar K., Goldsmith J. D., Nanthakumar N., Cheknis A., Gerding D. N., Kelly C. P.. 2008; A mouse model of Clostridium difficile-associated disease. Gastroenterology135:1984–1992 [CrossRef][PubMed]
    [Google Scholar]
  4. Fang A., Gerson D. F., Demain A. L.. 2009; Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests. Proc Natl Acad Sci U S A106:13225–13229 [CrossRef]
    [Google Scholar]
  5. Fujitani S., George W. L., Murthy A. R.. 2011; Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol32:220–228 [CrossRef][PubMed]
    [Google Scholar]
  6. Happel K. I., Dubin P. J., Zheng M., Ghilardi N., Lockhart C., Quinton L. J., Odden A. R., Shellito J. E., Bagby G. J. et al. 2005; Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae . J Exp Med202:761–769 [CrossRef][PubMed]
    [Google Scholar]
  7. Hasegawa M., Yamazaki T., Kamada N., Tawaratsumida K., Kim Y. G., Núñez G., Inohara N.. 2011; Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol186:4872–4880 [CrossRef][PubMed]
    [Google Scholar]
  8. Hirota S. A., Iablokov V., Tulk S. E., Schenck L. P., Becker H., Nguyen J., Al Bashir S., Dingle T. C., Laing A. et al. 2012; Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure. Infect Immun80:4474–4484 [CrossRef][PubMed]
    [Google Scholar]
  9. Huang W., Na L., Fidel P. L., Schwarzenberger P.. 2004; Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis190:624–631 [CrossRef][PubMed]
    [Google Scholar]
  10. Inui M., Ishida Y., Kimura A., Kuninaka Y., Mukaida N., Kondo T.. 2011; Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression. J Immunol186:423–431 [CrossRef][PubMed]
    [Google Scholar]
  11. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A. et al. 2009; Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity30:108–119 [CrossRef][PubMed]
    [Google Scholar]
  12. Issa M., Vijayapal A., Graham M. B., Beaulieu D. B., Otterson M. F., Lundeen S., Skaros S., Weber L. R., Komorowski R. A. et al. 2007; Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol5:345–351 [CrossRef][PubMed]
    [Google Scholar]
  13. Jarchum I., Liu M., Shi C., Equinda M., Pamer E. G.. 2012; Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun80:2989–2996 [CrossRef][PubMed]
    [Google Scholar]
  14. Jovanovic D. V., Di Battista J. A., Martel-Pelletier J., Jolicoeur F. C., He Y., Zhang M., Mineau F., Pelletier J. P.. 1998; IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol160:3513–3521[PubMed]
    [Google Scholar]
  15. Kelly C. P., Becker S., Linevsky J. K., Joshi M. A., O'Keane J. C., Dickey B. F., LaMont J. T., Pothoulakis C.. 1994; Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J Clin Invest93:1257–1265[CrossRef]
    [Google Scholar]
  16. Lochner M., Peduto L., Cherrier M., Sawa S., Langa F., Varona R., Riethmacher D., Si-Tahar M., Di Santo J. P., Eberl G.. 2008; In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med205:1381–1393 [CrossRef][PubMed]
    [Google Scholar]
  17. McDermott A. J., Falkowski N. R., McDonald R. A., Pandit C. R., Young V. B., Huffnagle G. B.. 2016; Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice. Immunology147:114–124 [CrossRef][PubMed]
    [Google Scholar]
  18. McDonald D. R.. 2012; TH17 deficiency in human disease. J Allergy Clin Immunol129:1429–1435 [CrossRef][PubMed]
    [Google Scholar]
  19. Miller B. A., Chen L. F., Sexton D. J., Anderson D. J.. 2011; Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol32:387–390 [CrossRef][PubMed]
    [Google Scholar]
  20. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y.. 2002; Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity17:375–387 [CrossRef][PubMed]
    [Google Scholar]
  21. O'Connor J. R., Johnson S., Gerding D. N.. 2009; Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology136:1913–1924 [CrossRef][PubMed]
    [Google Scholar]
  22. Pappu R., Ramirez-Carrozzi V., Ota N., Ouyang W., Hu Y.. 2010; The IL-17 family cytokines in immunity and disease. J Clin Immunol30:185–195 [CrossRef][PubMed]
    [Google Scholar]
  23. Qiu B., Pothoulakis C., Castagliuolo I., Nikulasson S., LaMont J. T.. 1999; Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats. Am J Physiol276:G485–G490[PubMed]
    [Google Scholar]
  24. Sorg J. A., Dineen S. S.. 2009; Laboratory maintenance of Clostridium difficile. Curr Protoc MicrobiolChapter 9:1 [CrossRef][PubMed]
    [Google Scholar]
  25. Sun X., Wang H., Zhang Y., Chen K., Davis B., Feng H.. 2011; Mouse relapse model of Clostridium difficile infection. Infect Immun79:2856–2864 [CrossRef][PubMed]
    [Google Scholar]
  26. Takahashi N., Vanlaere I., de Rycke R., Cauwels A., Joosten L. A., Lubberts E., van den Berg W. B., Libert C.. 2008; IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med205:1755–1761 [CrossRef][PubMed]
    [Google Scholar]
  27. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., Belladonna M. L., Vacca C., Conte C. et al. 2007; IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol37:2695–2706 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000273
Loading
/content/journal/jmm/10.1099/jmm.0.000273
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error